Lymph node melanocytic nevi: Pathogenesis and differential diagnoses, with special reference to p16 reactivity

Simonetta Piana, Elena Tagliavini, Moira Ragazzi, Magda Zanelli, Iris Zalaudek, Alessia Ciarrocchi, Riccardo Valli

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Lymph node nevi (NN) have been occasionally described, yet little is currently known on their origin. According to a theoretical model of nevogenesis, the dissemination of nevus progenitor cells through lymphatic routes is responsible for the development of both nodal and skin nevi.The true incidence of NN is largely unknown but it has been reported to vary from 0.017% to as high as 22%. The frequency of NN nevi has increased since the introduction of sentinel lymph node mapping as a routine prognostic procedure in breast cancer and melanoma.The aim of this study was to analyze the frequency and morphological findings of NN, to discuss possible pathogenetic pathways in their evolution, and to verify the consistency of p16 immunostaining in the critical differential approach between NN and melanoma metastases.We therefore morphologically and immunohistochemically evaluated a series of 60 NN from 58 patients. In 21 patients, the lymph nodes had been removed during the staging for a skin melanoma; in all these patients NN immunostaining with p16 was strongly positive and p16 proved to be a reliable marker for the crucial differential diagnosis between NN and melanoma metastasis, strongly reacting in NN and lacking in melanoma deposits.A deeper knowledge on NN could help to clarify some important topics such as lymph node metastatic melanoma with unknown primary and the current debate on the lymph node involvement from atypical spitzoid tumors.

Original languageEnglish
Pages (from-to)381-388
Number of pages8
JournalPathology Research and Practice
Volume211
Issue number5
DOIs
Publication statusPublished - May 1 2015

Fingerprint

Pigmented Nevus
Nevus
Differential Diagnosis
Lymph Nodes
Melanoma
Nevi and Melanomas
Neoplasm Metastasis
Skin
Theoretical Models
Stem Cells

Keywords

  • Lymph node
  • Melanocytic nevi
  • Metastasis
  • Nevogenesis
  • Nodal nevi
  • P16

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Cell Biology

Cite this

Lymph node melanocytic nevi : Pathogenesis and differential diagnoses, with special reference to p16 reactivity. / Piana, Simonetta; Tagliavini, Elena; Ragazzi, Moira; Zanelli, Magda; Zalaudek, Iris; Ciarrocchi, Alessia; Valli, Riccardo.

In: Pathology Research and Practice, Vol. 211, No. 5, 01.05.2015, p. 381-388.

Research output: Contribution to journalArticle

@article{9ed88cbde4ba4dffb1cbecd5d750e7c3,
title = "Lymph node melanocytic nevi: Pathogenesis and differential diagnoses, with special reference to p16 reactivity",
abstract = "Lymph node nevi (NN) have been occasionally described, yet little is currently known on their origin. According to a theoretical model of nevogenesis, the dissemination of nevus progenitor cells through lymphatic routes is responsible for the development of both nodal and skin nevi.The true incidence of NN is largely unknown but it has been reported to vary from 0.017{\%} to as high as 22{\%}. The frequency of NN nevi has increased since the introduction of sentinel lymph node mapping as a routine prognostic procedure in breast cancer and melanoma.The aim of this study was to analyze the frequency and morphological findings of NN, to discuss possible pathogenetic pathways in their evolution, and to verify the consistency of p16 immunostaining in the critical differential approach between NN and melanoma metastases.We therefore morphologically and immunohistochemically evaluated a series of 60 NN from 58 patients. In 21 patients, the lymph nodes had been removed during the staging for a skin melanoma; in all these patients NN immunostaining with p16 was strongly positive and p16 proved to be a reliable marker for the crucial differential diagnosis between NN and melanoma metastasis, strongly reacting in NN and lacking in melanoma deposits.A deeper knowledge on NN could help to clarify some important topics such as lymph node metastatic melanoma with unknown primary and the current debate on the lymph node involvement from atypical spitzoid tumors.",
keywords = "Lymph node, Melanocytic nevi, Metastasis, Nevogenesis, Nodal nevi, P16",
author = "Simonetta Piana and Elena Tagliavini and Moira Ragazzi and Magda Zanelli and Iris Zalaudek and Alessia Ciarrocchi and Riccardo Valli",
year = "2015",
month = "5",
day = "1",
doi = "10.1016/j.prp.2015.01.003",
language = "English",
volume = "211",
pages = "381--388",
journal = "Pathology Research and Practice",
issn = "0344-0338",
publisher = "Elsevier GmbH",
number = "5",

}

TY - JOUR

T1 - Lymph node melanocytic nevi

T2 - Pathogenesis and differential diagnoses, with special reference to p16 reactivity

AU - Piana, Simonetta

AU - Tagliavini, Elena

AU - Ragazzi, Moira

AU - Zanelli, Magda

AU - Zalaudek, Iris

AU - Ciarrocchi, Alessia

AU - Valli, Riccardo

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Lymph node nevi (NN) have been occasionally described, yet little is currently known on their origin. According to a theoretical model of nevogenesis, the dissemination of nevus progenitor cells through lymphatic routes is responsible for the development of both nodal and skin nevi.The true incidence of NN is largely unknown but it has been reported to vary from 0.017% to as high as 22%. The frequency of NN nevi has increased since the introduction of sentinel lymph node mapping as a routine prognostic procedure in breast cancer and melanoma.The aim of this study was to analyze the frequency and morphological findings of NN, to discuss possible pathogenetic pathways in their evolution, and to verify the consistency of p16 immunostaining in the critical differential approach between NN and melanoma metastases.We therefore morphologically and immunohistochemically evaluated a series of 60 NN from 58 patients. In 21 patients, the lymph nodes had been removed during the staging for a skin melanoma; in all these patients NN immunostaining with p16 was strongly positive and p16 proved to be a reliable marker for the crucial differential diagnosis between NN and melanoma metastasis, strongly reacting in NN and lacking in melanoma deposits.A deeper knowledge on NN could help to clarify some important topics such as lymph node metastatic melanoma with unknown primary and the current debate on the lymph node involvement from atypical spitzoid tumors.

AB - Lymph node nevi (NN) have been occasionally described, yet little is currently known on their origin. According to a theoretical model of nevogenesis, the dissemination of nevus progenitor cells through lymphatic routes is responsible for the development of both nodal and skin nevi.The true incidence of NN is largely unknown but it has been reported to vary from 0.017% to as high as 22%. The frequency of NN nevi has increased since the introduction of sentinel lymph node mapping as a routine prognostic procedure in breast cancer and melanoma.The aim of this study was to analyze the frequency and morphological findings of NN, to discuss possible pathogenetic pathways in their evolution, and to verify the consistency of p16 immunostaining in the critical differential approach between NN and melanoma metastases.We therefore morphologically and immunohistochemically evaluated a series of 60 NN from 58 patients. In 21 patients, the lymph nodes had been removed during the staging for a skin melanoma; in all these patients NN immunostaining with p16 was strongly positive and p16 proved to be a reliable marker for the crucial differential diagnosis between NN and melanoma metastasis, strongly reacting in NN and lacking in melanoma deposits.A deeper knowledge on NN could help to clarify some important topics such as lymph node metastatic melanoma with unknown primary and the current debate on the lymph node involvement from atypical spitzoid tumors.

KW - Lymph node

KW - Melanocytic nevi

KW - Metastasis

KW - Nevogenesis

KW - Nodal nevi

KW - P16

UR - http://www.scopus.com/inward/record.url?scp=84955185060&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955185060&partnerID=8YFLogxK

U2 - 10.1016/j.prp.2015.01.003

DO - 10.1016/j.prp.2015.01.003

M3 - Article

C2 - 25661066

AN - SCOPUS:84955185060

VL - 211

SP - 381

EP - 388

JO - Pathology Research and Practice

JF - Pathology Research and Practice

SN - 0344-0338

IS - 5

ER -